Citadel Advisors - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 79 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$663,683
-3.3%
28,706
+9.6%
0.00%
Q2 2023$686,466
-38.2%
26,181
-39.3%
0.00%
Q1 2023$1,110,758
-76.0%
43,153
-75.7%
0.00%
-100.0%
Q4 2022$4,623,173
-41.9%
177,746
-36.2%
0.00%
-50.0%
Q3 2022$7,955,000
+61.9%
278,795
+39.7%
0.00%
+100.0%
Q2 2022$4,914,000
-13.0%
199,615
+99.4%
0.00%0.0%
Q1 2022$5,649,000
+68.2%
100,099
+84.7%
0.00%0.0%
Q4 2021$3,358,000
-69.2%
54,182
-68.5%
0.00%
-50.0%
Q3 2021$10,920,000
-83.7%
172,136
-78.8%
0.00%
-86.7%
Q2 2021$66,919,000
+13.5%
812,025
+1.3%
0.02%
+7.1%
Q1 2021$58,958,000
+2.5%
801,391
+1.1%
0.01%
-6.7%
Q4 2020$57,493,000
+59.0%
792,786
+4.5%
0.02%
+50.0%
Q3 2020$36,161,000
-6.9%
758,579
-18.0%
0.01%
-28.6%
Q2 2020$38,837,000
+52.5%
924,681
-2.0%
0.01%
+27.3%
Q1 2020$25,469,000
-28.9%
943,295
+1.3%
0.01%
-31.2%
Q4 2019$35,829,000
+24.8%
930,869
-29.7%
0.02%
+14.3%
Q3 2019$28,700,0001,323,8170.01%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 5,831,307$480,558,00031.49%
Consonance Capital Management LP 1,199,339$98,838,00011.90%
Boxer Capital, LLC 2,075,905$171,075,0006.04%
Perceptive Advisors 9,699,824$799,362,0005.19%
Orbimed Advisors 6,044,266$498,108,0005.04%
Samsara BioCapital, LLC 169,852$13,998,0001.73%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,375,775$113,378,0001.50%
SPHERA FUNDS MANAGEMENT LTD. 195,117$16,080,0001.09%
Artal Group S.A. 500,000$41,205,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 558,574$46,032,0000.82%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders